How severe is CVE-2017-17677?

CVE-2017-17677 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2017-17677 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (68th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2017-17677?

CVE-2017-17677 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2017-17677?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2017-17677 published?

CVE-2017-17677 was published on 2021-05-19 and last updated on 2026-07-05.

CVE-2017-17677

CVE-2017-17677 is a high-severity vulnerability in Bmc Remedy Mid-tier with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-732.

Key facts

Severity: High (CVSS 3.x base score 8.8)
CVSS v2: 6.5
EPSS exploit prediction: 1% (68th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-732
Affected product: Bmc Remedy Mid-tier
Published: 2021-05-19
Last modified: 2026-07-05

Description

BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.

Frequently asked questions

What is CVE-2017-17677?: BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
How severe is CVE-2017-17677?: CVE-2017-17677 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2017-17677 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (68th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2017-17677?: CVE-2017-17677 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2017-17677?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2017-17677 published?: CVE-2017-17677 was published on 2021-05-19 and last updated on 2026-07-05.

References

Affected products (1)

cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*

More vulnerabilities in Bmc Remedy Mid-tier

CVE-2024-34399 — Critical (CVSS 9.8): **UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. An unauthenticated remote attacker…
CVE-2017-17674 — Critical (CVSS 9.8): BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can…
CVE-2018-18862 — High (CVSS 8.8): BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms, as…
CVE-2017-17678 — Medium (CVSS 6.1): BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability…
CVE-2017-17675 — Medium (CVSS 5.3): BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated users,…
CVE-2024-34398 — Medium (CVSS 4.2): An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by…

All CVEs affecting Bmc Remedy Mid-tier →

Other CWE-732 (Incorrect Permission Assignment for Critical Resource) vulnerabilities

CVE-2026-9508 — Critical (CVSS 10.0): Incorrect permission settings on a critical resource in Suprema BioStar 2 (versions 2.9.3 through 2.9.11) that allow…
CVE-2025-14988 — Critical (CVSS 10.0): A security issue has been identified in ibaPDA that could allow unauthorized actions on the file system under certain…
CVE-2025-69426 — Critical (CVSS 10.0): The Ruckus vRIoT IoT Controller firmware versions prior to 3.0.0.0 (GA) contain hardcoded credentials for an operating…
CVE-2025-12004 — Critical (CVSS 10.0): Incorrect Permission Assignment for Critical Resource vulnerability in The Wikimedia Foundation Mediawiki - Lockdown…
CVE-2014-125121 — Critical (CVSS 10.0): Array Networks vAPV (version 8.3.2.17) and vxAG (version 9.2.0.34) appliances are affected by a privilege escalation…
CVE-2025-46093 — Critical (CVSS 9.9): LiquidFiles before 4.1.2 supports FTP SITE CHMOD for mode 6777 (setuid and setgid), which allows FTPDrop users to…

Browse all CWE-732 (Incorrect Permission Assignment for Critical Resource) vulnerabilities →